HTB homepage • Conference reports • Articles by subject • Subscribe June 2009 Contents Editorial Volume 10 Number 5/6 May/June 2009 Conference reports 15th Annual Conference of the British HIV Association (BHIVA), 1-3 April 2009, Liverpool Superinfection identified in 2 out of 8 patients with unexpected viral load increases Peripheral DEXA scans to identify rates of reduced bone mineral density Vitamin D deficiency, supplementation and tenofovir High rate of lost and untested TB biopsy samples and low screening for latent TB 16th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 February 2009, Montreal Assessing the cardiovascular impact of HIV, abacavir, and new signals for lopinavir/r Intensive smoking cessation programme reports limited success at 6 months HDL particle concentration predicts cardiovascular disease in SMART No effect of hormonal contraception on HIV disease progression in large multi-country cohort Pregnancy, family planning, and HIV acquisition in HPTN 039 Progression and regression of pre-malignant cervical lesions in HIV-positive women from Soweto CD4 count >250 not predictive of rash-associated hepatoxicity among women initiating nevirapine-based ART in Zambia, Thailand, and Kenya HIV testing of infants at immunisation clinics in Kwazulu-Natal Rapid HIV disease progression in South African infants co-infected with cytomegalovirus (CMV) Pharmacokinetic studies in very young infants Double-dose lopinavir/ritonavir provides insufficient lopinavir exposure in children receiving rifampicin PI-based ART in children with HIV and HIV/TB coinfection in South Africa Etravirine dose selection in children aged 6 to 17 Preliminary results from first paediatric raltegravir study 10th International Workshop on Clinical Pharmacology of HIV Therapy, 15-17 April 2009, Amsterdam Efavirenz lowers levels of darunavir given as 900/100mg once daily with ritonavir How much (or how little) ritonavir do you need to boost another PI? Genetic markers linked to early discontinuation of three antiretrovirals 4th South African AIDS Conference, 31 March-3 April 2009, Durban, South Africa HAART coverage and unmet need in South Africa Antiretrovirals EMEA positive opinion on using tipranavir and darunavir in younger patients Lopinavir/r (Kaletra) cardiovascular risk requires FDA label changes NEJM paper: NA-ACCORD cohort study on when to start treatment NA ACCORD results support the importance of the START study: response to researchers EMEA statement on abacavir and the risk of heart attack Treatment access Access to HIV treatment for UK prisoners PK and drug interactions Potential interactions between antiviral treatment for swine flu (H1N1) and anti-HIV therapy Case reports of significant interactions between etravirine and raltegravir Guidelines HIV and hepatitis coinfection guidelines (2009): online for comment US pregnancy guidelines updated (2009) Cure-related research Update on (another) Berlin patient Basic science and immunology Whole body CD4 T cell census questions role of gut Gut bacteria breach the barrier: further confirmation of microbial translocation in HIV infection BHIVA news BHIVA research awards deadline Other news Iowa: Gay man gets 25 years for one-time non-disclosure to a single complainant US denies entry to 60 HIV-positive Canadians Job vacancy: Editor post for of the Southern African Journal on HIV Medicine for the nursing profession PDFs Volume 10 Number 5/6 May/June 2009 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
